Produktname:Methyl 4-chloroimidazo[1,2-a]quinoxaline-8-carboxylate
IUPAC Name:methyl 4-chloroimidazo[1,2-a]quinoxaline-8-carboxylate
- CAS：1452864-18-4
- Molekulare Formel：C12H8ClN3O2
- Reinheit：97%
- Katalognummer：CM221313
- Molekulargewicht：261.67
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1452864-18-4
- Molekulare Formel:C12H8ClN3O2
- Schmelzpunkt:-
- SMILES-Code:O=C(C1=CC2=C(C=C1)N=C(Cl)C3=NC=CN32)OC
- Dichte:
- Katalognummer:CM221313
- Molekulargewicht:261.67
- Siedepunkt:
- Mdl-Nr.:MFCD26407246
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
- Imidazopyrazines
- In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.
Suche 
+86 21 5895 0110 
